GPT and Cirrhosis: Several international hepatology societies suggest that NAs treatment can be stopped in selected patients, particularly those without cirrhosis and with persistent normal alanine aminotransferase (ALT) and undetectable hepatitis B virus (HBV) DNA (5–7).